Source comparison
CJC-1295 No DAC Stack Comparison
CJC-1295 no DAC + GHRP-2 High (15–20ng/mL) Moderate ghrelin specificity 12+ weeks sustainable Mild hunger, occasional flushing Most balanced option for long-term research. Strong efficacy without desensitisation concerns CJC-1295 no DAC + Ipamorelin Moderate-H
This comparison does not assign a generated winner or score.
- CJC-1295 no DAC + GHRP-2
- High (15–20ng/mL)
- Moderate ghrelin specificity
- 12+ weeks sustainable
- Mild hunger, occasional flushing
- Most balanced option for long-term research. Strong efficacy without desensitisation concerns
- CJC-1295 no DAC + Ipamorelin
- Moderate-High (12–16ng/mL)
- High ghrelin specificity
- 16+ weeks sustainable
- Minimal. No cortisol or prolactin elevation
- Ideal for protocols requiring minimal secondary hormone disruption
- CJC-1295 no DAC + Hexarelin
- Very High (20–25ng/mL)
- 2-week cycles only
- Cortisol elevation, receptor desensitisation
- Highest GH output but requires cycling to prevent tolerance
- CJC-1295 no DAC + GHRP-6
- High (16–22ng/mL)
- Low ghrelin specificity
- 8–12 weeks with monitoring
- Significant hunger stimulation, water retention
- Effective but hunger side effects limit usability in calorie-restricted research
- CJC-1295 no DAC alone
- Moderate (4–6ng/mL)
- GHRH-specific
- Continuous use acceptable
- Minimal
- Baseline effectiveness. Stacking produces 3–4× higher output